Michael  Gold  to  Quality-Adjusted Life Years
                            
                            
                                This is a "connection" page, showing publications  Michael  Gold  has written about  Quality-Adjusted Life Years.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.897
         
        
        
     
 
    
        
        - 
            Economic Value and Cost-Effectiveness of?Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up. JACC Heart Fail. 2017 03; 5(3):204-212.
            
            
                Score: 0.522
            
         
        
        - 
            Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care. 1998 Jun; 36(6):778-92.
            
            
                Score: 0.144
            
         
        
        - 
            Economic implications and cost-effectiveness of implantable cardioverter defibrillator and cardiac resynchronization therapy. Heart Fail Clin. 2011 Apr; 7(2):241-50, ix.
            
            
                Score: 0.087
            
         
        
        - 
            Improving value measurement in cost-effectiveness analysis. Med Care. 2000 Sep; 38(9):892-901.
            
            
                Score: 0.042
            
         
        
        - 
            Toward a broader view of values in cost-effectiveness analysis of health. Hastings Cent Rep. 1999 May-Jun; 29(3):7-15.
            
            
                Score: 0.038
            
         
        
        - 
            Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996 Oct 16; 276(15):1253-8.
            
            
                Score: 0.032
            
         
        
        - 
            The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996 Oct 09; 276(14):1172-7.
            
            
                Score: 0.032